1Johnson MK. The delayed neurotic effect of some organophos-phours compounds:identification of the phosphorylation site as an esterase. Biochem J, 1969,114:711-717.
2Johnson MK. Impeoved assay of neurotoxic esterase of screening organophosphates for delayed neurotoxicity potential. Arch Toxicity, 1977,37 ; 113-115.
4Escudero MA, Sogorb MA, Vilanova E. An automatable microassay for phenyl valerate esterase activities sensitive to organophosphorus compounds. Toxicol lett, 1996,89 : 241-247.
5Sigolaeva LV, Eremenko AV, Makower A, et al. A new approach for neuropathy target esterase. Chem Biol Interact, 1999, 119-120 : 559-565.
6Dudek BR, Richardson RJ. Evidence for the existence of neurotoxic esterase in neural and lymphatic tissue of the adult hen.Biochem Pharmacol, 1982,31 : 1117-1121.
7Willams DG. lntramolecular group transfer is a characteristic of neurotoxic esterase andis independent of the tissue source of the enzyme. Biochem J, 1983,209 : 817-829.
8Glynn P. Neuropathy target esterase (NTE) : Moleucular charac-terisation and cellular localisation. Arch Toxicol Suppl, 1997,19:325-329.
9Glynn P, Hubbard A, Cavanagh JB. Neuropathy target esterase:immunolocalization to neuronal cell bodies and axons. Neuroscience, 1998,83:295-302.
10Kamijima M,Casida JE. Localization of [3 H]-labeled neuropathy target esterase by chicken nervous tissue autoradiography.Neurosci lett, 1999,273 : 101-104.
7Dyck PJ, Johnson WJ, Lambert EH, et al. Segmental demyelination secondary to axonal degeneration in uremic neuropathy [J]. Mayo Clin Proc, 1971, 46 (6): 400-412.
